If you ask the average person on the street what they know of gene therapy, you will most likely get a puzzled expression. This exciting branch of modern science has been revolutionized by a highly successful and driven man: Eric Leire. Dr. Leire is the CEO and founder of GenFlow Biosciences, and boasts a plethora of experience from being CEO of several successful cell & gene therapy biotech companies and working at major pharmaceutical companies such as Pfizer and also conducting research at Harvard. A French/American dual citizen, he has founded a company that is exciting, successful, and driven to disrupting modern science and treatment.
For those that are ignorant, Gene Therapy is defined “as a technique that uses genes to treat or prevent disease. This technology allows doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.” (Source)
GenFlow Biosciences believes in a world devoid of suffering, where aging is seen as a risk factor that can be managed, rather than an inevitable fate with disease, disorder, and degeneration. Dr. Leire believes aging is due to the “accumulated DNA damage that occurs over time” and that with his innovative gene delivery, gene therapy can actually achieve regeneration and recovery from this damage. In other words, GenFlow Biosciences is advocating and seeking to accomplish a “facelift” from the inside, a revival of youth and exuberance in those who are aged, disabled and diseased.
Although today people are living longer statistically, many argue we are merely “dying longer”, with the years of ill-health and suffering merely extended through medications and medical intervention. Leire and his team believe that cells need to be ‘boosted’ so that people can enjoy abundant and thriving health even in their 70s, 80s, and beyond. Leire believes aging is unnatural and can be managed and prevented through gene therapy. Even the terrifying illness of dementia and Alzheimer’s can be treated through gene therapy. This exciting science signals hope for those who are currently witnessing their loved ones suffering from cognitive decline and the inevitable hardship and distress that this illness brings.
We all know what it is like to see a picture of our grandmother and grandfather when they were young. The faded black and white photos showing a vibrant glimpse into the lives of our elders from years before. However, this often fills us with a sense of sadness and dread at the inevitability of aging. We not only see how time can deteriorate our physical condition but also how physically taxing aging is. We look at our young grandmother, dark-haired and wrinkle-free and we don’t recognize the stooped over, coughing and ill grandmother we have become accustomed to seeing. Could there be a cure for aging?
Dr. Leire believes that we need to change our collective mindset about aging, and rather see aging as a disease. Leire believes that he as a scientist has an ethical principle and obligation to share his gifts and passion and to help a generation of people to live longer, healthier, and enjoyable lives, not terrified under the dark cloud of threats such as cancer, dementia, and strokes. Living a joyful and healthy life is our birthright, Leire believes.
GenFlow Biosciences is at a major crossroads as the company is on the verge of going public. This will ensure investors and like-minded passionate people can share their beliefs and vigor in the purpose of the company.
Dr. Leire believes that more copies of the “SIRT6” gene will ensure that people live longer, enjoy healthier aging, and avoid chronic disease. This is a gene that is found in centenarians, evidence that it is essential to healthy aging. Leire spent much time with his team assembling and studying the medical data to make a clear conclusion. If you are curious about the science, just have a look at GenFlow Bioscience website where they update their page with regular news, studies, and podcasts.
The treatment with “SIRT6” gene therapy is safe and has been subject to medical regulations. Dr. Leire believes that the team will create a therapy in which people will be infused with the gene therapy, and this may, in fact, add 4-5 years of healthy lifespan to participants.
This science is exciting and a testament to the potential of modern science to revolutionize what we think and about normal aging. Clearly, in the wake of a global pandemic, many investors will be keen to share in the potential and future GenFlow Biosciences. Dr. Leire has even used studies on elephants to prove how humans can add years to their life. This study is available on the GenFlow Biosciences website.
It is an exciting time for GenFlow Biosciences and their gene therapy is destined to revolutionize modern science and our social beliefs about aging and decline. Dr. Leire has used his experience and gifts to build a pioneering therapy that achieves a beautiful thing: ending suffering.